newsfilter
← Latest News
Business Wire·

AlloVir Appoints Shawn Tomasello to Its Board of Directors

AlloVir (NASDAQ:ALVR), a late-clinical stage allogeneic T-cell immunotherapy company, today announced the appointment of Shawn Tomasello to its Board of Directors. Ms. Tomasello brings more than 35 years of broad experience building and leading commerci